Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Shares withheld for taxes Chief Medical Officer gave up 7,566 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 7,566 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 13,384 shares (to pay taxes)
  5. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,599 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Shares withheld for taxes Chief Medical Officer gave up 6,120 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 10,827 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 6,120 shares (to pay taxes)
  10. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,205 shares (to pay taxes)
  11. 4 Open-market sale Director sold 1,250 shares at $2.07 ($2,588)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 5,316 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 5,316 shares (to pay taxes)
  14. 4 Shares withheld for taxes General Counsel, Secretary gave up 990 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 13,357 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Medical Officer gave up 14,391 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 14,035 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 39,248 shares (to pay taxes)
  19. 4 Shares withheld for taxes General Counsel, Secretary gave up 31,505 shares (to pay taxes)
  20. 4 Grant or award Chief Scientific Officer acquired 93,766 shares (grant or award)

Page 5 of 13 · 246 filings